TransCode Therapeutics, Inc.(RNAZ)
$2.18—Stale · unknown old
TransCode Therapeutics, Inc.(RNAZ)
NASDAQ • Last print unknown ago
$2.18—Stale · unknown old
Buy1 analyst
Key Metrics
TTMMarket Cap$2.31M
Revenue TTM$0.00
Price / Sales—
Net Income TTM-$42.78M
Free Cash Flow-$5.00B
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-58.1%
Return on Assets-28.3%
Debt / Equity (MRQ)0.00
Current Ratio (MRQ)1.97
EPS TTM$-45.65
PRICE
Prev Close
2.28
Open
2.12
Day Range2.09 – 2.22
2.09
2.22
52W Range2.09 – 20.99
2.09
20.99
0% of range
50-Day MA
5.43(-59.9%)
200-Day MA
7.61(-71.3%)
VOLUME & SIZE
Avg Volume
69.6K
FUNDAMENTALS
P/E (TTM)
-0.0x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
Beta
1.34
Market-like
TECHNICAL
RSI (14)
22
Oversold